Breast Cancer
Conference Coverage
Ten Years of Adjuvant Tamoxifen Found Superior to Five
Major Finding: Women randomized to 10 years of adjuvant tamoxifen had a 25% reduction in recurrences and a 29% lower mortality due to breast...
Video
ONC-CHAT - What Did You Learn at the Meeting Today?
News
Doubling Fulvestrant Dose Extends Breast Cancer Survival
Major Finding: Postmenopausal patients with estrogen receptor–positive advanced breast cancer treated with intramuscular fulvestrant at 500 mg had...
Conference Coverage
Less Invasive Biopsy Used Less in Black Breast Cancer Patients
Major Finding: From 2002 to 2007, significantly fewer black women than white women with invasive breast cancer underwent a sentinel lymph node...
Conference Coverage
Experimental Drug Puts ER-Positive Breast Cancer on Hold
Major Finding: Compared with letrozole alone, letrozole plus PD 0332991 was associated with significantly better progression-free survival (26.1...
Video
San Antonio Roundtable, Part 1: Fulvestrant Dose and Tamoxifen Duration
Conference Coverage
Breast Cancer: Molecular Profiling Doesn't Trump Standard Pathology
News
Surviving breast cancer shouldn't mean relinquishing intimacy
News
Rapid Feedback Boosts Adherence to Oncology Quality Measures
Major Finding: Compliance rates for five quality measures climbed to as high as 90% in centers that used RQRS.Data Source: Data on 31,590 breast...